ARMOND PEINTURE DECORBusiness Directories,Company Directories

Company Name: Corporate Name:	ARMOND PEINTURE & DECOR
Company Title:
Company Description:
Keywords to Search:
Company Address:	800 Rue Du Conseil,SHERBROOKE,QC,Canada
ZIP Code: Postal Code:	J1G
Telephone Number:	8195697095
Fax Number:	8199866171
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	248490
USA SIC Description:	WALLPAPERS & WALLCOVERINGS
Number of Employees:
Sales Amount:	Less than $500,000
Credit History: Credit Report:	Unknown
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
ARMSTRONG INDUSTRIAL SUPPLIES
ARMSTRONG INDUSTRIAL SUPPLIES LTD
ARMSTRONG DISTRIBUTORS LTD

Next company profile:
ARMOIRES DE CUISINE ANDRE BEAUCHESN
ARMOIRE DE CUISINE IMAGINE INC
ARMEE DU SALUT

Company News:

Immunic, Inc. Common Stock (IMUX) - Nasdaq
Discover real-time Immunic, Inc Common Stock (IMUX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions Stay ahead with Nasdaq
Immunic, Inc. Common Stock (IMUX) Pre-Market Quotes | Nasdaq
Get the latest updates on Immunic, Inc Common Stock (IMUX) pre market trades, share volumes, and more Make informed investments with Nasdaq
Immunic (IMUX) Q2 Loss Widens 25% - Nasdaq
Immunic (NASDAQ:IMUX), a late-stage biotechnology company focused on autoimmune and inflammatory diseases, released its second quarter 2025 results on August 7, 2025
Immunic Stock (NASDAQ:IMUX): Exploring the Promising Phase 2 CALLIPER . . .
Immunic, Inc (IMUX) is a clinical-stage biotechnology company, headquartered in New York City
Immunics Oral IMU-856 Demonstrated Dose-Dependent Increase of . . . - Nasdaq
NEW YORK, Feb 20, 2025 PRNewswire -- Immunic, Inc (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic
Immunic Stock (NASDAQ:IMUX): CEO Says Right Time to Buy Now
Immunic (IMUX) is a clinical-stage biotechnology company focused on developing small-molecule therapies for treating chronic inflammatory and autoimmune diseases
Immunic Stock (IMUX): Striving to Develop Innovative Therapies - Nasdaq
Based out of Germany, and headquartered in New York, Immunic (NASDAQ:IMUX) is a clinical-stage biotechnology company
New Analyst Forecast: $IMUX Given Outperform Rating - Nasdaq
We just received data on a new analyst forecast for $IMUX William Blair gave a rating of 'Outperform' for $IMUX
Immunic, Inc. Common Stock (IMUX) Historical Data | Nasdaq
Find the latest historical data for Immunic, Inc Common Stock (IMUX) at Nasdaq com View historical data in a monthly, bi-annual, or yearly format
Immunic Reports Q3 Earnings and Provides Corporate Update - Nasdaq
Immunic (IMUX) reported better-than-expected earnings for the third quarter of Fiscal 2024 on November 7